2024 annual financial data

Puma Biotechnology 2024 Financial results

Direct answer

Revenue was 230,468,000 USD.

Operating income was 30,966,000 USD and net income was 30,278,000 USD.
Operating cash flow was 38,918,000 USD.

Get free Puma Biotechnology email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
230,468,000 USD
Operating income
30,966,000 USD
Net income
30,278,000 USD
Operating cash flow
38,918,000 USD